Background and aims: The objectives of this study were to investigate the cyto-molecular
profile and survival of pediatric acute myeloid leukemia (AML). Methods: This prospective …

Background: Acute myeloid leukemia (AML) accounts for 15%-20% of childhood leukemia.
A variety of cytogenetic abnormalities have been reported in AML, but it is still debated how …

Background. Advances in genomic techniques have recently shed light on leukemia biology,
recognizing that pediatric acute myeloid leukemia (AML) is a highly genetically …

Objective: To describe the epidemiological profile, cytogenetic and molecular aberrations
and the survival rate of patients with acute myeloid leukemia (AML) in a province reference …

Background The objectives of this study were to investigate the mutation profiles of targeted
genes and copy number variations (CNVs) in normal cytogenetics (CN) pediatric acute …

The classification of acute myeloid leukemia (AML) has evolved to the most recent World
Health Organization (WHO) schema, which integrates genetic, morphologic, and prognostic …

Pediatric acute myeloid leukemia (AML) is a heterogeneous disease with various genetic
abnormalities. Recent advances in genetic analysis have enabled the identification of …

Introduction: Currently, most phenotypic, cytogenetic or molecular markers identified in
children with acute myeloid leukemia (AML) are not used for risk stratification or treatment …

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease
accounting for 15–20% of all childhood acute leukemias, while it is responsible for more …

The incidence of cytogenetic abnormalities in childhood de novo acute myeloid leukaemia
(AML) and its prognostic significance was assessed in an Israeli paediatric referral centre …